Poseida TherapeuticsPSTX
PSTX
$3.37
6.65%
Market Cap: $327M
0
Funds holding %
of 6,728 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
656% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $175K
100% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]
73% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 22
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
2% more funds holding
Funds holding: 89 [Q1] → 91 (+2) [Q2]
0.53% less ownership
Funds ownership: 55.14% [Q1] → 54.61% (-0.53%) [Q2]
9% less capital invested
Capital invested by funds: $170M [Q1] → $155M (-$15.1M) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$20
493%
upside
Avg. target
$20
493%
upside
High target
$20
493%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Arthur He 37% 1-year accuracy 7 / 19 met price target | 493%upside $20 | Buy Reiterated | 6 Aug 2024 |
HC Wainwright & Co. Arthur He 37% 1-year accuracy 7 / 19 met price target | 493%upside $20 | Buy Reiterated | 25 Jul 2024 |
Financial journalist opinion
Based on 5 articles about PSTX published over the past 30 days